Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × fludarabine × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Multiple Myeloma 13 Lymphoma 12 Myelodysplastic Syndromes 11 Lymphoma, Non-Hodgkin 10 Leukemia, Lymphocytic, Chronic, B-Cell 9 Recurrence 8 Lymphoma, Large B-Cell, Diffuse 8 Myeloproliferative Disorders 6 Melanoma 6 Lymphoma, Follicular 6 Lymphoma, B-Cell 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Neoplasms 5 Leukemia, Biphenotypic, Acute 5 Leukemia 5 Hodgkin Disease 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Lymphoma, Mantle-Cell 4 Hematologic Neoplasms 4 Burkitt Lymphoma 4 Anemia, Refractory, with Excess of Blasts 4 Primary Myelofibrosis 3 Neoplasm Metastasis 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelomonocytic, Chronic 3 Glioblastoma 3 Colorectal Neoplasms 3

Interventions

pembrolizumab 15 enfortumab vedotin 10 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡